# Evofem Biosciences Inc. (EVFM)

Source: https://www.quantisnow.com/company/EVFM
Generated: 2026-11-16T00:03:31.545Z

- Ticker: EVFM
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2014
- SEC CIK: 0001618835
- Website: evofem.com

## About

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. It has a collaboration agreement with National Community Oncology Dispensing Association, Inc. to educate oncology community about Phexxi. Evofem Biosciences, Inc. is headquartered in San Diego, California.

## Latest EVFM news and filings

- 2026-11-13 21:59 UTC [SEC Form 8-K] [Evofem Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/evofem-biosciences-inc-filed-sec-form-8-k-results-of-operations-6791275)
- 2026-11-13 21:57 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Evofem Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-evofem-biosciences-inc-6791262)
- 2026-10-15 20:05 UTC [SEC Form 8-K] [SEC Form 8-K filed by Evofem Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-evofem-biosciences-inc-6748015)
- 2026-09-23 20:05 UTC [SEC Form 8-K] [Evofem Biosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/evofem-biosciences-inc-filed-sec-form-8-k-entry-into-a-6724136)
- 2026-07-20 20:14 UTC [SEC Form 8-K] [Evofem Biosciences Inc. filed SEC Form 8-K: Regulation FD Disclosure](https://www.quantisnow.com/insight/evofem-biosciences-inc-filed-sec-form-8-k-regulation-fd-disclosure-6642514)
- 2026-07-14 20:31 UTC [SEC Form 8-K] [Evofem Biosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits](https://www.quantisnow.com/insight/evofem-biosciences-inc-filed-sec-form-8-k-entry-into-a-6636962)
- 2026-07-01 11:00 UTC [HUB Cyber Security Expands Into Women’s Health With Zero-Cash Acquisition of Evofem Notes, Advances Balance Sheet Turnaround](https://www.quantisnow.com/insight/hub-cyber-security-expands-into-womens-health-with-zero-cash-acquisition-6621731)
- 2026-05-18 12:56 UTC [SEC Form 8-K] [Evofem Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/evofem-biosciences-inc-filed-sec-form-8-k-results-of-operations-6559404)
- 2026-05-15 21:05 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Evofem Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-evofem-biosciences-inc-6558320)
- 2026-04-30 20:05 UTC [SEC Form 8-K] [Evofem Biosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/evofem-biosciences-inc-filed-sec-form-8-k-entry-into-a-6524190)
- 2026-04-16 20:05 UTC [SEC Form 8-K] [Evofem Biosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/evofem-biosciences-inc-filed-sec-form-8-k-entry-into-a-6503133)
- 2026-03-19 20:05 UTC [SEC Form 8-K] [Evofem Biosciences Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/evofem-biosciences-inc-filed-sec-form-8-k-termination-of-a-6461422)
- 2026-03-11 20:48 UTC [SEC Form 8-K] [SEC Form 8-K filed by Evofem Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-evofem-biosciences-inc-6442512)
- 2026-03-11 20:43 UTC [SEC Form 10-K] [SEC Form 10-K filed by Evofem Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-evofem-biosciences-inc-6442408)
- 2026-01-12 22:01 UTC [SEC Form 8-K] [Evofem Biosciences Inc. filed SEC Form 8-K: Regulation FD Disclosure](https://www.quantisnow.com/insight/evofem-biosciences-inc-filed-sec-form-8-k-regulation-fd-disclosure-6346793)
- 2025-11-26 21:49 UTC [SEC Form 8-K] [Evofem Biosciences Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/evofem-biosciences-inc-filed-sec-form-8-k-amendments-to-articles-6295437)
- 2025-11-21 14:25 UTC [Favorable Pricing Certificates Issued for Evofem's PHEXX by Emirates Drug Establishment are Launching Step for Commercialization in UAE](https://www.quantisnow.com/insight/favorable-pricing-certificates-issued-for-evofems-phexx-by-emirates-drug-6289836)
- 2025-11-13 21:19 UTC [SEC Form 8-K] [Evofem Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/evofem-biosciences-inc-filed-sec-form-8-k-results-of-operations-6277697)
- 2025-11-13 21:05 UTC [Earnings] [Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update](https://www.quantisnow.com/insight/evofem-reports-financial-results-for-third-quarter-of-2025-provides-6277314)
- 2025-11-13 21:01 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Evofem Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-evofem-biosciences-inc-6277189)
- 2025-10-29 20:05 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Evofem Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-evofem-biosciences-inc-6249880)
- 2025-10-20 21:25 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Evofem Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-evofem-biosciences-inc-6238927)
- 2025-10-20 21:22 UTC [SEC Form 8-K] [Evofem Biosciences Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/evofem-biosciences-inc-filed-sec-form-8-k-termination-of-a-6238914)
- 2025-10-20 20:19 UTC [Evofem Announces Voting Results from Special Meeting of Stockholders](https://www.quantisnow.com/insight/evofem-announces-voting-results-from-special-meeting-of-stockholders-6238627)
- 2025-10-17 20:05 UTC [SEC Form 8-K] [Evofem Biosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/evofem-biosciences-inc-filed-sec-form-8-k-entry-into-a-6236926)
- 2025-10-01 12:47 UTC [Evofem's SOLOSEC Submitted for Marketing Approval in United Arab Emirates](https://www.quantisnow.com/insight/evofems-solosec-submitted-for-marketing-approval-in-united-arab-emirates-6217325)
- 2025-09-26 12:15 UTC [Evofem Biosciences Honors World Contraception Day](https://www.quantisnow.com/insight/evofem-biosciences-honors-world-contraception-day-6212626)
- 2025-09-19 21:24 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Evofem Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-evofem-biosciences-inc-6207101)
- 2025-09-09 20:05 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Evofem Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-evofem-biosciences-inc-6194973)
- 2025-09-09 13:28 UTC [Evofem Anticipates Approval of Merger with Aditxt at Upcoming Stockholder Meeting](https://www.quantisnow.com/insight/evofem-anticipates-approval-of-merger-with-aditxt-at-upcoming-stockholder-6194609)
- 2025-09-05 22:46 UTC [SEC Form DEFM14A] [SEC Form DEFM14A filed by Evofem Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-defm14a-filed-by-evofem-biosciences-inc-6192310)
- 2025-08-26 21:23 UTC [SEC Form PREM14A filed by Evofem Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-prem14a-filed-by-evofem-biosciences-inc-6179588)
- 2025-08-26 20:13 UTC [SEC Form 8-K] [Evofem Biosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/evofem-biosciences-inc-filed-sec-form-8-k-entry-into-a-6179223)
- 2025-08-21 12:56 UTC [Illinois Pharmacists Can Prescribe PHEXXI Starting January 2026 Under Newly-passed Law](https://www.quantisnow.com/insight/illinois-pharmacists-can-prescribe-phexxi-starting-january-2026-under-newly-passed-6174498)
- 2025-08-19 13:39 UTC [FDA Orange Book Lists New U.S. Patent for SOLOSEC, Evofem Biosciences' "One and Done" Oral Treatment for Bacterial Vaginosis and Trichomoniasis](https://www.quantisnow.com/insight/fda-orange-book-lists-new-us-patent-for-solosec-evofem-6171251)
- 2025-08-14 12:50 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Evofem Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-evofem-biosciences-inc-6164797)
- 2025-08-14 12:48 UTC [SEC Form 8-K] [Evofem Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/evofem-biosciences-inc-filed-sec-form-8-k-results-of-operations-6164795)
- 2025-08-14 12:46 UTC [Dividends] [Evofem Reports Positive Financial Results for Second Quarter of 2025, Provides Business Update](https://www.quantisnow.com/insight/evofem-reports-positive-financial-results-for-second-quarter-of-2025-6164789)
- 2025-08-05 12:46 UTC [Evofem CEO Saundra Pelletier Honored with Trailblazing Female Founders Award at STIMULATE Conference](https://www.quantisnow.com/insight/evofem-ceo-saundra-pelletier-honored-with-trailblazing-female-founders-award-6146575)
- 2025-07-24 20:06 UTC [SEC Form PREM14A filed by Evofem Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-prem14a-filed-by-evofem-biosciences-inc-6131578)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/EVFM
- Earnings history: https://www.quantisnow.com/earnings/EVFM
- Dividend history: https://www.quantisnow.com/dividends/EVFM
- Insider transactions: https://www.quantisnow.com/insiders/EVFM
- Options chain: https://www.quantisnow.com/options/EVFM
- SEC 8-K filings only: https://www.quantisnow.com/company/EVFM/8-k
- RSS and alerts for EVFM: https://www.quantisnow.com/docs/rss-feeds.md
